Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph L. Turner currently holds 4,312 shares of Arcutis Biotherapeutics, Inc. (ARQT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph L. Turner has been a net seller of ARQT stock. They have purchased $20.1K and sold $3.0M worth of shares.
Joseph L. Turner's most recent insider trade was on Jun 1, 2022, when they sold 4,312 shares at $0.00 per share.
Joseph L. Turner serves as Executive at Arcutis Biotherapeutics, Inc. (ARQT). They have executed 45 insider transactions totaling $3.0M over their tenure at the company.
Joseph L. Turner holds the position of Executive at Arcutis Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Joseph L. Turner has shown a selling trading pattern, with $20.1K in total purchases and $3.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joseph L. Turner was on Mar 1, 2006, when they sold $285.5K worth of MYOG shares. This transaction involved 7,500 shares at $38.07 per share.
Joseph L. Turner currently owns 4,312 shares of Arcutis Biotherapeutics, Inc. (ARQT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph L. Turner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph L. Turner has 45 Form 4 filings on record as an insider at Arcutis Biotherapeutics, Inc..
Set alerts for Joseph L. Turner and 40,000+ other insiders.